CYTRABINE (CYTOSAR) INJECTION – TREATMENT FOR BLOOD CANCER
Some blood malignancies are treated with cytosar injection. According to the doctor’s judgment, it may also be used to treat other disorders. It is occasionally used in combination with specific other medications as part of chemotherapy.
The healthcare provider injects Cytosar Injection into a vein or beneath the skin. Your doctor will determine the appropriate dosage and frequency of administration for you. This is based on the condition you are being treated for and is subject to change.
USES OF CYTRABINE (CYTOSAR) INJECTION
- Blood cancer
WORKS OF CYTRABINE (CYTOSAR) INJECTION
By swapping their building ingredients, Cytosar Injection prevents the cancer cell’s DNA and RNA from growing. It stops the growth and reproduction of cancer cells.
SIDE EFFECTS OF CYTRABINE (CYTOSAR) INJECTION
- Skin ulcer
- Hair loss
- Abdominal pain
- Anal ulcers
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Abnormal liver function
- Low blood platelets
- Mouth ulcer
- Mouth sore
- Stomatitis (Inflammation of the mouth)
WARNING & PRECAUTIONS
Your ability to drive may be impacted by side effects from cytosar injection.
Patients with kidney disease can take Cytosar Injection without risk. Cytosar Injection should not have its dosage adjusted.
However, if you have any kidney illness at all, talk to your doctor.
On the usage of Cytosar Injection in patients with liver disease, there is not much information currently available. Please speak with your physician.
The use of Cytosar Injection in patients with liver disease is advised with caution due to the paucity of available information.
Fedelty Health Care is a Cytrabine third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.